featured
Canagliflozin in Type 1 Diabetic Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, as Add-On to Insulin in Patients With Type 1 Diabetes
Diabetes Care 2015 Oct 20;[EPub Ahead of Print], RR Henry, P Thakkar, C Tong, D Polidori, M AlbaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.